These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 39396941)

  • 21. Design and baseline characteristics of the ILD-PRO registry in patients with progressive pulmonary fibrosis.
    Lobo LJ; Liu Y; Li P; Ramaswamy M; Swaminathan AC; Veeraraghavan S; Fan Y; Neely ML; Palmer SM; Olson AL;
    BMC Pulm Med; 2024 Sep; 24(1):468. PubMed ID: 39334205
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence and prognosis of unclassifiable interstitial lung disease.
    Ryerson CJ; Urbania TH; Richeldi L; Mooney JJ; Lee JS; Jones KD; Elicker BM; Koth LL; King TE; Wolters PJ; Collard HR
    Eur Respir J; 2013 Sep; 42(3):750-7. PubMed ID: 23222877
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Integration and Application of Radiologic Patterns From Clinical Practice Guidelines on Idiopathic Pulmonary Fibrosis and Fibrotic Hypersensitivity Pneumonitis.
    Marinescu DC; Hague CJ; Muller NL; Murphy D; Churg A; Wright JL; Al-Arnawoot A; Bilawich AM; Bourgouin P; Cox G; Durand C; Elliot T; Ellis J; Fisher JH; Fladeland D; Grant-Orser A; Goobie GC; Guenther Z; Haider E; Hambly N; Huynh J; Johannson KA; Karjala G; Khalil N; Kolb M; Leipsic J; Lok S; MacIsaac S; McInnis M; Manganas H; Marcoux V; Mayo J; Morisset J; Scallan C; Sedlic T; Shapera S; Sun K; Tan V; Wong AW; Zheng B; Ryerson CJ
    Chest; 2023 Dec; 164(6):1466-1475. PubMed ID: 37541339
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Design and rationale of the Japanese Idiopathic Interstitial Pneumonias (JIPS) Registry.
    Okuda R; Ogura T; Hisata S; Baba T; Kondoh Y; Suda T; Johkoh T; Iwasawa T; Tomioka H; Bando M; Azuma A; Inoue Y; Arai T; Nakamura Y; Miyamoto A; Miyazaki Y; Chiba H; Ishii H; Hamada N; Terasaki Y; Kuwahira I; Sato S; Kato S; Suzuki T; Sakamoto S; Nishioka Y; Hattori N; Hashimoto N; Morita S; Ichihara N; Miyata H; Hagiwara K; Nukiwa T; Kobayashi K
    Respir Investig; 2023 Jan; 61(1):95-102. PubMed ID: 36580379
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Unclassifiable interstitial lung diseases: Clinical characteristics and survival.
    Hyldgaard C; Bendstrup E; Wells AU; Hilberg O
    Respirology; 2017 Apr; 22(3):494-500. PubMed ID: 28297158
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A cohort study of interstitial lung diseases in central Denmark.
    Hyldgaard C; Hilberg O; Muller A; Bendstrup E
    Respir Med; 2014 May; 108(5):793-9. PubMed ID: 24636811
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence and characteristics of progressive fibrosing interstitial lung disease in a prospective registry.
    Hambly N; Farooqi MM; Dvorkin-Gheva A; Donohoe K; Garlick K; Scallan C; Chong SG; MacIsaac S; Assayag D; Johannson KA; Fell CD; Marcoux V; Manganas H; Morisset J; Comes A; Fisher JH; Shapera S; Gershon AS; To T; Wong AW; Sadatsafavi M; Wilcox PG; Halayko AJ; Khalil N; Cox G; Richeldi L; Ryerson CJ; Kolb M
    Eur Respir J; 2022 Oct; 60(4):. PubMed ID: 35273032
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Interstitial lung diseases : Classification, differential diagnosis and treatment approaches in a heterogeneous group of chronic lung disorders].
    Lederer C; Buschulte K; Hellmich B; Heußel CP; Kriegsmann M; Polke M; Kreuter M
    Inn Med (Heidelb); 2023 Mar; 64(3):247-259. PubMed ID: 36786822
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of an interstitial lung disease service in the diagnosis and management of interstitial lung disease in Singapore.
    Chai GT; Tan TC; Lee YS; Kaw GJ; Chuah KL; Lim YJ; Abisheganaden JA; Thong BY
    Singapore Med J; 2020 Jun; 61(6):302-307. PubMed ID: 31317200
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Idiopathic Interstitial Pneumonia Associated With Autoantibodies: A Large Case Series Followed Over 1 Year.
    Collins BF; Spiekerman CF; Shaw MA; Ho LA; Hayes J; Spada CA; Stamato CM; Raghu G
    Chest; 2017 Jul; 152(1):103-112. PubMed ID: 28300570
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Progressive fibrosing interstitial lung diseases: A new concept and indication of nintedanib.
    Makino S
    Mod Rheumatol; 2021 Jan; 31(1):13-19. PubMed ID: 32964766
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transbronchial Lung Cryobiopsy and Surgical Lung Biopsy: A Prospective Multi-Centre Agreement Clinical Trial (CAN-ICE).
    Fortin M; Liberman M; Delage A; Dion G; Martel S; Rolland F; Soumagne T; Trahan S; Assayag D; Albert E; Kelly MM; Johannson KA; Guenther Z; Leduc C; Manganas H; Prenovault J; Provencher S
    Am J Respir Crit Care Med; 2023 Jun; 207(12):1612-1619. PubMed ID: 36796092
    [No Abstract]   [Full Text] [Related]  

  • 33. Clinical profile of unclassifiable interstitial lung disease: Comparison with chronic fibrosing idiopathic interstitial pneumonias.
    Traila D; Oancea C; Tudorache E; Mladinescu OF; Timar B; Tudorache V
    J Int Med Res; 2018 Jan; 46(1):448-456. PubMed ID: 28758849
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Real-world utility of a genomic classifier in establishing a diagnosis of newly identified interstitial lung disease.
    Abdalla M; Castellani C; Singh H; Kurman JS; Benn BS
    Respir Med Res; 2023 Jun; 83():100996. PubMed ID: 36812772
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Unclassifiable interstitial lung disease: from phenotyping to possible treatments.
    Guler SA; Ryerson CJ
    Curr Opin Pulm Med; 2018 Sep; 24(5):461-468. PubMed ID: 30004990
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Deep learning diagnostic and severity-stratification for interstitial lung diseases and chronic obstructive pulmonary disease in digital lung auscultations and ultrasonography: clinical protocol for an observational case-control study.
    Siebert JN; Hartley MA; Courvoisier DS; Salamin M; Robotham L; Doenz J; Barazzone-Argiroffo C; Gervaix A; Bridevaux PO
    BMC Pulm Med; 2023 Jun; 23(1):191. PubMed ID: 37264374
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nationwide epidemiologic study for fibrosing interstitial lung disease (F-ILD) in South Korea: a population-based study.
    Joung KI; Park H; Park S; Shin JY; Kim YH
    BMC Pulm Med; 2023 Mar; 23(1):98. PubMed ID: 36949407
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The accuracy of the clinical diagnosis of new-onset idiopathic pulmonary fibrosis and other interstitial lung disease: A prospective study.
    Raghu G; Mageto YN; Lockhart D; Schmidt RA; Wood DE; Godwin JD
    Chest; 1999 Nov; 116(5):1168-74. PubMed ID: 10559072
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of Multidisciplinary Team Meetings in the Diagnosis and Management of Diffuse Parenchymal Lung Diseases in a Tertiary Care Hospital.
    Khan MA; Sherbini N; Alyami S; Al-Harbi A; Alrajhi S; Abdullah R; AlGhamdi D; Rajendram R; Bamefleh H; Al-Jahdali H
    Avicenna J Med; 2023 Oct; 13(4):230-236. PubMed ID: 38144909
    [No Abstract]   [Full Text] [Related]  

  • 40. CT Features of the Usual Interstitial Pneumonia Pattern: Differentiating Connective Tissue Disease-Associated Interstitial Lung Disease From Idiopathic Pulmonary Fibrosis.
    Chung JH; Cox CW; Montner SM; Adegunsoye A; Oldham JM; Husain AN; Vij R; Noth I; Lynch DA; Strek ME
    AJR Am J Roentgenol; 2018 Feb; 210(2):307-313. PubMed ID: 29140119
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.